Although certain details, such as the transcriptional activation of PCBP2 by EGFR and the validation of the PCBP2-miRNA complex in OSCC patients, still lack direct evidence, this study represents a significant contribution to the ongoing topic of EGFR-driven tumor angiogenesis. This evidence concerns the gene PCBP2 and neoplasm.